Hans Peter Hasler
InvestorPräsident (President of the Board of Directors) at HBM Healthcare Investments
About
Hans Peter Hasler has chaired the board of directors of HBM Healthcare Investments since 2009 and serves on its audit committee. He was CEO of Vicarius Pharma from 2017 to 2020 and previously held international leadership roles at Wyeth Pharmaceuticals, Biogen Inc., and Elan Corporation. He holds a Swiss federal commercial diploma and a marketing certificate from the Schweizerisches Institut für Betriebsökonomie (SIB) in Zurich.
Investments
Board seats
Gain TherapeuticsMinerva NeurosciencesShield Therapeutics plc
Per the firm's website.
Colleagues at HBM Healthcare Investments
Andreas Wicki
CEO at HBM Healthcare Investments
Dr Elaine V. Jones
Verwaltungsratsmitglied at HBM Healthcare Investments
Dr. Rudolf Lanz
Verwaltungsratsmitglied at HBM Healthcare Investments
Dr. Stella Xu
Verwaltungsratsmitglied at HBM Healthcare Investments
Erwin Troxler
CFO at HBM Healthcare Investments
Mario G. Giuliani
Verwaltungsratsmitglied at HBM Healthcare Investments
Frequently asked questions
- Who is Hans Peter Hasler?
- Hans Peter Hasler has chaired the board of directors of HBM Healthcare Investments since 2009 and serves on its audit committee. He was CEO of Vicarius Pharma from 2017 to 2020 and previously held international leadership roles at Wyeth Pharmaceuticals, Biogen Inc., and Elan Corporation. He holds a Swiss federal commercial diploma and a marketing certificate from the Schweizerisches Institut für Betriebsökonomie (SIB) in Zurich.
- Where does Hans Peter Hasler work?
- Hans Peter Hasler is Präsident (President of the Board of Directors) at HBM Healthcare Investments.
- What boards does Hans Peter Hasler sit on?
- Hans Peter Hasler holds tracked board seats at Gain Therapeutics, Minerva Neurosciences, Shield Therapeutics plc.